HCM
CASI

Howland Capital Management’s CASI Pharmaceuticals CASI Stock Holding History

Howland Capital Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,072
Closed -$82.9K – 278
2024
Q2 		$82.9K Sell
15,072
-25,357
-63% -$78.8K ﹤0.01% 272
2024
Q1 		$146K Buy
+40,429
New +$218K 0.01% 262
2017
Q4 		– Sell
-2,414
Closed -$43K – 221
2017
Q3 		$43K Buy
+2,414
New +$28.2K ﹤0.01% 220

Other funds holding CASI

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Howland Capital Management's CASI Position: Q3 2024 in Review

Howland Capital Management sold out of CASI Pharmaceuticals (CASI) in Q3 2024, closing a stake of 15,072 shares — an estimated $82.9K sold.

Howland Capital Management first reported a position in CASI in Q3 2017 and held it in 3 quarters. The position peaked at $146K in Q1 2024. 20 funds tracked by Wall St. Rank hold CASI as of Q3 2024.

  • Howland Capital Management reported no remaining CASI Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Howland Capital Management sold 15,072 CASI Pharmaceuticals shares in Q3 2024, an estimated $82.9K.
  • Howland Capital Management first reported a position in CASI Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • Howland Capital Management's CASI Pharmaceuticals position peaked at $146K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2024.

Based on Howland Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.